risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. “Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) semaglutide with thyroid issues medullary
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) semaglutide with thyroid issues medullary](https://revivifymedicalspa.com/wp-content/uploads/2024/08/02-99-1024x683.jpg)
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) semaglutide with thyroid issues medullary](https://www.diabetesincontrol.com/wp-content/uploads/2026/03/glp1-thyroid-cancer-human-data-research.png)
![risk of medullary thyroid cancer with glp 1 Ozempic and Wegovy increase cancer. Use of GLP-1 RA for 1-3 years was associated increased risk of all thyroid (adjusted hazard ratio [HR] 1.58, 95% CI 1.27-1.95) semaglutide with thyroid issues medullary](https://cdn.prod.website-files.com/62aec59ac7c1e4f6f1719e4a/69038751ff304cd2192eb5a5_rectFUCWwSlQjE4VT.png)



















